Back to calendar
Latigo Biotherapeutics, Inc. (LTGO) Earnings
LTGO reports earnings on Thursday, September 3, 2026
earnings report
September 3, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.63
Actual EPS: $-0.56
EPS surprise: -5.41%
Company overview
Market Cap$1.5B
PriceUSD 23.04
52-week high25.93
52-week low17.22
SectorHealth Technology
IndustryPharmaceuticals: Major